甲状腺がんの遺伝子変異に対する腫瘍マイクロ環境の影響

Lingyan Zhou¹, Shujian Xu¹, Yuwen Song²

¹Department of Endocrinology and Metabolism, The Second Qilu Hospital of Shandong University, Jinan, Shandong, China.

PloS one

|February 12, 2026

まとめ

甲状腺がんの免疫療法は調査中です. この研究は,BRAFのような遺伝子変異を腫瘍の微環境と結びつけ,BRAF抑制された腫瘍が免疫療法に反応する可能性があることを示唆しています.

科学分野:

腫瘍学腫瘍学
ゲノミクスゲノミクスとは
免疫学免疫学とは

背景:

甲状腺がん (THCA) の免疫療法反応は,肺がんやメラノーマとは異なり,ほとんど知られていない.
THCAの腫瘍微環境 (TME) と遺伝的景観を理解することは,効果的な免疫療法の開発に不可欠です.

研究の目的:

THCAにおける遺伝子変異とTMEとの関係を調査する.
THCA免疫療法の潜在的な治療標的を特定する.

主な方法:

571個のTHCAサンプル (TCGA) のRNAシーケンシングと体的変異データを分析した.
ESTIMATEおよびCIBERSORTアルゴリズムを使用して,免疫およびストロマスコアを評価し,腫瘍に浸透する免疫細胞 (TIC) を定量化しました.
差別的に発現する遺伝子 (DEGs) と差別的に変異した遺伝子 (DMGs) を特定し,臨床病理学的特徴と免疫チェックポイントタンパク質 (ICPs) と関連付けました.

主要な成果:

BRAF,NRAS,HRASの突然変異の頻度において,免疫およびストロマのサブグループ間で顕著な差異が見つかりました.
BRAF/NRAS発現は,THCAの臨床段階と相関しています.
BRAF発現は11の活性化されたTICと関連しており,抑制されたBRAF発現は上調されたICPと相関していた.

結論:

遺伝子変異,特にBRAFは,THCA TMEの形成に重要な役割を果たしています.
抑制されたBRAF発現を持つTHCAは,免疫チェックポイントブロック免疫療法に敏感である可能性があり,潜在的な治療戦略を強調しています.

さらに関連する動画

10:23

Author Spotlight: Computing the Effects of a Local Radiofrequency Hyperthermia Intervention on Tumor Biomechanics

Published on: December 1, 2023

1.0K

03:41

High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model

Published on: October 11, 2022

2.3K

関連する概念動画

01:09

Mutation, Gene Flow, and Genetic Drift

64.6K

In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).

64.6K

02:17

The Tumor Microenvironment

7.9K

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Mutations

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...

44.7K

00:36

Viral Mutations

40.0K

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...

40.0K

01:23

The Thyroid Gland

7.8K

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...